• News

    Market Watch

    November 1, 2009

    Discontinued Products Amoxicillin powder for oral suspension and pediatric drops for oral suspension1 Amoxicillin powder for oral suspension (Amoxil brand usually for adults), 250mg/5mL (100mL and 150mL sizes)2 Insulin isophane suspension (Humulin 50/50), due to limited use.3 Current pa

  • News

    Market Watch

    October 1, 2009

    In the Pipeline A new drug application (NDA) has been submitted to the Food and Drug Administration (FDA) for Acetavance, an intravenous (IV) form of acetaminophen used in the treatment of acute pain and fever in adults and children who cannot take oral medications.1 An NDA for a low-dose a

  • News

    Market Watch

    August 1, 2009

    Product Withdrawal Efalizumab (Raptiva), the once-weekly monoclonal antibody used to treat moderate to severe plaque psoriasis, has been withdrawn from the U.S.

  • News

    Increased Attention

    July 2, 2009

    Identify, evaluate, monitor patients to prevent drug-induced conditions

  • News

    Head Off Hypoglycemia

    June 1, 2009

    History, communication, and deduction can solve drug-induced dilemmas

  • News

    Up Close and Personal

    May 2, 2009

    Medication reaction research could streamline drug trials, improve outcomes

  • News

    C. Difficile Infection: Are We Doing Enough?

    April 21, 2009

    Hospitalists can follow simple steps to avoid, manage this costly disease

  • News

    To Crush or Not to Crush

    April 1, 2009

    Do your homework before breaking down medications

  • News

    QTc Interval Prolongation

    February 1, 2009

    Know your patient’s history, drug combinations before starting a new treatment

  • News

    Inhaled Insulin: Troubled Drug Rises from the Ashes

    January 1, 2009

    Pfizer is out, but three competitors are charging ahead with production